Market Cap 1.52B
Revenue (ttm) 1.31B
Net Income (ttm) 132.42M
EPS (ttm) N/A
PE Ratio 11.56
Forward PE 11.31
Profit Margin 10.13%
Debt to Equity Ratio 0.91
Volume 476,400
Avg Vol 380,402
Day's Range N/A - N/A
Shares Out 30.94M
Stochastic %K 2%
Beta 1.20
Analysts Sell
Price Target $65.67

Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides suppor...

Industry: Medical Devices
Sector: Healthcare
Phone: 727 392 6464
Address:
11311 Concept Boulevard, Largo, United States
ZacksResearch
ZacksResearch Jul. 10 at 2:50 PM
$CNMD down 22.7% so far this year — is this medical player ready to bounce back? 📉 With a solid product lineup and improved margins, CONMED's 2025 outlook looks promising despite supply-chain and data security challenges. The company expects continued growth as hospital systems prioritize minimally invasive procedures. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2570795/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2570795-body-1180&ADID=SYND_STOCKTWITS_TWEET_2_2570795_BODY_1180
0 · Reply
ZacksResearch
ZacksResearch Jul. 10 at 11:43 AM
$CNMD is holding strong — here’s why it still deserves a spot in your portfolio 👇 Recurring revenues are solid, margins are improving, and surgical product growth continues — even with supply and cybersecurity headwinds. Full breakdown here 👉 https://www.zacks.com/stock/news/2570795/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2570795-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2570795_TEASER
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 9 at 1:55 PM
$CNMD Excellent article that nails exactly where CNMD stands right now. So if you want to update your CNMD knowledge or get acquainted with CNMD, this is a must read. https://beyondspx.com/article/conmed-s-growth-engine-powers-through-operational-headwinds-nyse-cnmd
0 · Reply
Estimize
Estimize Jul. 8 at 12:03 PM
Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/30 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
themacromindset
themacromindset Jul. 7 at 9:00 PM
$CNMD Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.
0 · Reply
transcendingaling
transcendingaling Jun. 28 at 9:41 PM
$CNMD am I missing something here? Looks like an easy add
0 · Reply
Estimize
Estimize Jun. 23 at 12:03 PM
Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/23 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize Jun. 9 at 12:03 PM
Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/23 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
ParkerDeckerOnline
ParkerDeckerOnline May. 16 at 4:59 PM
0 · Reply
Estimize
Estimize May. 7 at 1:06 PM
Wall St is expecting 1.11 EPS for $CNMD Q2 [Reporting 07/23 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
Latest News on CNMD
CONMED Corporation Announces Quarterly Cash Dividend

May 21, 2025, 7:00 AM EDT - 2 months ago

CONMED Corporation Announces Quarterly Cash Dividend


CONMED Corporation (CNMD) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 9:52 PM EDT - 2 months ago

CONMED Corporation (CNMD) Q1 2025 Earnings Call Transcript


CONMED Corporation Adds Mark Kaye to its Board of Directors

Feb 25, 2025, 7:03 AM EST - 5 months ago

CONMED Corporation Adds Mark Kaye to its Board of Directors


These Analysts Slash Their Forecasts On Conmed After Q4 Results

Feb 6, 2025, 6:57 AM EST - 5 months ago

These Analysts Slash Their Forecasts On Conmed After Q4 Results


CONMED Corporation (CNMD) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 7:05 PM EST - 5 months ago

CONMED Corporation (CNMD) Q4 2024 Earnings Call Transcript


Top 3 Health Care Stocks That May Dip This Month

Nov 25, 2024, 8:29 AM EST - 8 months ago

Top 3 Health Care Stocks That May Dip This Month

BFLY MDGL


CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 9:21 PM EDT - 9 months ago

CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript


CONMED Corporation Announces Leadership Succession

Oct 30, 2024, 4:02 PM EDT - 9 months ago

CONMED Corporation Announces Leadership Succession


CONMED Corporation (CNMD) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 10:33 PM EDT - 1 year ago

CONMED Corporation (CNMD) Q2 2024 Earnings Call Transcript


CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript

Apr 25, 2024, 1:16 AM EDT - 1 year ago

CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript


CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript

Jan 31, 2024, 9:17 PM EST - 1 year ago

CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript


CONMED Corporation (CNMD) Q3 2023 Earnings Call Transcript

Oct 25, 2023, 8:18 PM EDT - 1 year ago

CONMED Corporation (CNMD) Q3 2023 Earnings Call Transcript


CONMED Corporation (CNMD) Q2 2023 Earnings Call Transcript

Jul 26, 2023, 11:03 PM EDT - 2 years ago

CONMED Corporation (CNMD) Q2 2023 Earnings Call Transcript


Conmed: Updated Guidance Is Positive

May 19, 2023, 3:06 PM EDT - 2 years ago

Conmed: Updated Guidance Is Positive


CONMED Corporation (CNMD) Q1 2023 Earnings Call Transcript

Apr 26, 2023, 11:06 PM EDT - 2 years ago

CONMED Corporation (CNMD) Q1 2023 Earnings Call Transcript


CONMED Corporation Announces Annual Meeting of Stockholders

Mar 22, 2023, 4:05 PM EDT - 2 years ago

CONMED Corporation Announces Annual Meeting of Stockholders


ZacksResearch
ZacksResearch Jul. 10 at 2:50 PM
$CNMD down 22.7% so far this year — is this medical player ready to bounce back? 📉 With a solid product lineup and improved margins, CONMED's 2025 outlook looks promising despite supply-chain and data security challenges. The company expects continued growth as hospital systems prioritize minimally invasive procedures. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2570795/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2570795-body-1180&ADID=SYND_STOCKTWITS_TWEET_2_2570795_BODY_1180
0 · Reply
ZacksResearch
ZacksResearch Jul. 10 at 11:43 AM
$CNMD is holding strong — here’s why it still deserves a spot in your portfolio 👇 Recurring revenues are solid, margins are improving, and surgical product growth continues — even with supply and cybersecurity headwinds. Full breakdown here 👉 https://www.zacks.com/stock/news/2570795/heres-why-you-should-retain-conmed-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2570795-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2570795_TEASER
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 9 at 1:55 PM
$CNMD Excellent article that nails exactly where CNMD stands right now. So if you want to update your CNMD knowledge or get acquainted with CNMD, this is a must read. https://beyondspx.com/article/conmed-s-growth-engine-powers-through-operational-headwinds-nyse-cnmd
0 · Reply
Estimize
Estimize Jul. 8 at 12:03 PM
Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/30 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
themacromindset
themacromindset Jul. 7 at 9:00 PM
$CNMD Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.
0 · Reply
transcendingaling
transcendingaling Jun. 28 at 9:41 PM
$CNMD am I missing something here? Looks like an easy add
0 · Reply
Estimize
Estimize Jun. 23 at 12:03 PM
Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/23 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize Jun. 9 at 12:03 PM
Wall St is expecting 1.12 EPS for $CNMD Q2 [Reporting 07/23 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
ParkerDeckerOnline
ParkerDeckerOnline May. 16 at 4:59 PM
0 · Reply
Estimize
Estimize May. 7 at 1:06 PM
Wall St is expecting 1.11 EPS for $CNMD Q2 [Reporting 07/23 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
PandorasStox
PandorasStox May. 2 at 4:04 PM
$AEHL breakout coming here people get ready $WHLR $WULF $NDRA $CNMD
0 · Reply
JarvisFlow
JarvisFlow May. 1 at 3:29 PM
Wells Fargo updates rating for Conmed ( $CNMD ) to Equal-Weight, target set at 70 → 57.
0 · Reply
anachartanalyst
anachartanalyst May. 1 at 2:02 PM
$CNMD https://anachart.com/wp-content/uploads/ana_temp/1746108131_soc-img.jpg
0 · Reply
briefingcom
briefingcom May. 1 at 12:04 PM
Gapping up: $TTMI +16.3% $CNMD +11.8% $TNDM +10.3% $AAON +9.1% $MSFT +9.1%
0 · Reply
JarvisFlow
JarvisFlow May. 1 at 12:00 PM
Needham updates rating for Conmed ( $CNMD ) to Buy, target set at 91 → 61.
0 · Reply
swingingtech
swingingtech Apr. 25 at 4:04 PM
$IJS $CNMD $MTUS $PZZA https://wallstreetwaves.com/new-target-price-for-ijs-analyst-122/
0 · Reply
Estimize
Estimize Apr. 24 at 8:03 PM
Wall St is expecting 1.03 EPS for $CNMD Q2 [Reporting 07/23 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize Apr. 24 at 12:15 PM
Wall St is expecting 0.81 EPS for $CNMD Q1 [Reporting 04/30 AMC] http://www.estimize.com/intro/cnmd?chart=historical&metric_name=eps&utm_co
0 · Reply
PenkeTrading
PenkeTrading Apr. 9 at 1:39 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of CONMED Corporation. Is that bullish or bearish? $CNMD #CONMED #RsiOversold #NYSE
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 31 at 3:42 AM
$CNMD Digging the AirSeal platform growth. Might add more on next dip. Med tech looking strong for CNMD. Great writeup: https://beyondspx.com/article/conmed-corporation-cnmd-navigating-the-medical-technology-landscape-with-innovation-and-resilience
0 · Reply
StockAnalyticsAI
StockAnalyticsAI Mar. 24 at 9:39 AM
$CNMD Deep Dive 00:00 – Chapter 1: Business Analysis 05:59 – Chapter 2: Management Evaluation 09:10– Chapter 3: Financial Analysis 13:41 – Chapter 4: Market Sentiment 15:38 – Chapter 5: Ownership Structure 17:20 – Chapter 6: Risk Assessment 19:49 – Chapter 7: Conclusion https://youtu.be/Ei0cfTvlCDo?si=AbyXD9poUisky-Ii
0 · Reply